Turku PET Centre, University of Turku, Turku, Finland
Search for other papers by Jukka Koffert in
Google Scholar
PubMed
Search for other papers by Henri Honka in
Google Scholar
PubMed
Search for other papers by Jarmo Teuho in
Google Scholar
PubMed
Search for other papers by Saila Kauhanen in
Google Scholar
PubMed
Search for other papers by Saija Hurme in
Google Scholar
PubMed
Department of Radiology, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Riitta Parkkola in
Google Scholar
PubMed
Search for other papers by Vesa Oikonen in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Andreas Lindqvist in
Google Scholar
PubMed
Search for other papers by Nils Wierup in
Google Scholar
PubMed
Search for other papers by Leif Groop in
Google Scholar
PubMed
Department of Endocrinology, Turku University Hospital, Turku, Finland
Search for other papers by Pirjo Nuutila in
Google Scholar
PubMed
in line with our present study where GLP-1 leads to decrement in pancreatic BF, a tributary organ of SMA. However, why the jejunal BF remained unchanged despite the decrease in SMA BF cannot be answered on the basis of the present study but it may be
St Michael's Hospital, Metabolism Laboratory, School of Medicine and Medical Sciences, Dún Laoghaire, Dublin, Ireland
St Michael's Hospital, Metabolism Laboratory, School of Medicine and Medical Sciences, Dún Laoghaire, Dublin, Ireland
Search for other papers by Malachi J McKenna in
Google Scholar
PubMed
Search for other papers by Barbara F Murray in
Google Scholar
PubMed
constant of 2.5, and finally multiples the answer by 100 to estimate the required vitamin D dose (2, 8) . According to the findings of our report, this CPG rate constant on average underestimates the rate constant by twofold. The reason for the substantial
Search for other papers by Michelle Hadjiconstantinou in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Search for other papers by Hamidreza Mani in
Google Scholar
PubMed
Search for other papers by Naina Patel in
Google Scholar
PubMed
Search for other papers by Miles Levy in
Google Scholar
PubMed
Department of Diabetes and Endocrinology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK
Search for other papers by Melanie Davies in
Google Scholar
PubMed
Search for other papers by Kamlesh Khunti in
Google Scholar
PubMed
Search for other papers by Margaret Stone in
Google Scholar
PubMed
and there were positive feelings about the idea of having a specialist PCOS support nurse: ‘They’ve been helpful … just answering the questions that you’ve got, and just … reassuring.’ (Participant 4, age 17). ‘I feel like the access that you get
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
IMED Biotech Unit, Clinical Discovery Unit, AstraZeneca, UK
Search for other papers by Benjamin G Challis in
Google Scholar
PubMed
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Andrew S Powlson in
Google Scholar
PubMed
Search for other papers by Ruth T Casey in
Google Scholar
PubMed
Search for other papers by Carla Pearson in
Google Scholar
PubMed
Search for other papers by Brian Y Lam in
Google Scholar
PubMed
Search for other papers by Marcella Ma in
Google Scholar
PubMed
Search for other papers by Deborah Pitfield in
Google Scholar
PubMed
Search for other papers by Giles S H Yeo in
Google Scholar
PubMed
Search for other papers by Edmund Godfrey in
Google Scholar
PubMed
Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by Heok K Cheow in
Google Scholar
PubMed
Wolfson Diabetes and Endocrine Centre, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by V Krishna Chatterjee in
Google Scholar
PubMed
Search for other papers by Nicholas R Carroll in
Google Scholar
PubMed
Search for other papers by Ashley Shaw in
Google Scholar
PubMed
Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, UK
Search for other papers by John R Buscombe in
Google Scholar
PubMed
Search for other papers by Helen L Simpson in
Google Scholar
PubMed
, remains unclear and given the rarity of malignant insulinoma this question is unlikely to be answered in a sufficiently powered clinical trial. Through WES of tumour DNA, we and others demonstrate that benign and malignant insulinoma have a low frequency
Search for other papers by John E M Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
North Lakes Clinical, Department of Nuclear Medicine, Medical Department I, Ruhr Center for Rare Diseases (CeSER), 20 Wheatley Avenue, Ilkley LS29 8PT, UK
Search for other papers by Johannes W Dietrich in
Google Scholar
PubMed
Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
, age, height, weight, smoking habits (75% answered), prior surgery or radioiodine treatment, thyroid medication (brand, dosage, duration, time of intake), other drugs, laboratory tests (FT 3 , FT 4 , TSH and, if autoimmune thyroiditis was suspected or
Search for other papers by Jens P Goetze in
Google Scholar
PubMed
Search for other papers by Linda M Hilsted in
Google Scholar
PubMed
Search for other papers by Jens F Rehfeld in
Google Scholar
PubMed
Search for other papers by Urban Alehagen in
Google Scholar
PubMed
(27) . However, the contribution of cardiac CgA to plasma is more debatable, as for instance the adrenal medulla and the gastrointestinal tract are major sites of CgA production. Our results do not answer the question of organ specificity to the
Search for other papers by A J Varewijck in
Google Scholar
PubMed
Search for other papers by A J van der Lely in
Google Scholar
PubMed
Search for other papers by S J C M M Neggers in
Google Scholar
PubMed
Search for other papers by S W J Lamberts in
Google Scholar
PubMed
Search for other papers by L J Hofland in
Google Scholar
PubMed
Search for other papers by J A M J L Janssen in
Google Scholar
PubMed
Questionnaires Acromegaly Quality of Life Questionnaire The Acromegaly Quality of Life (AcroQoL) Questionnaire comprises 22 questions. Each question has five possible answers scored 1–5, with a total maximum score of 110 and quoted as a percentage. The score of
Search for other papers by Nadia Sawicka-Gutaj in
Google Scholar
PubMed
Search for other papers by Ariadna Zybek-Kocik in
Google Scholar
PubMed
Search for other papers by Michał Kloska in
Google Scholar
PubMed
Search for other papers by Paulina Ziółkowska in
Google Scholar
PubMed
Search for other papers by Agata Czarnywojtek in
Google Scholar
PubMed
Search for other papers by Jerzy Sowiński in
Google Scholar
PubMed
Search for other papers by Dorota Mańkowska-Wierzbicka in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
study, Caixas et al . observed that in hyperthyroid patients fat mass increases during the therapy with concomitant increase of visfatin ( 16 ). The design of the study does not enable to answer if observed visfatin changes during recovery in
Search for other papers by Jose M Garcia in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
Search for other papers by Vera Popovic in
Google Scholar
PubMed
Search for other papers by Anton Luger in
Google Scholar
PubMed
Search for other papers by Christian J Strasburger in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Search for other papers by Ronald Swerdloff in
Google Scholar
PubMed
Search for other papers by Christina Wang in
Google Scholar
PubMed
Search for other papers by Rosa Rosanna Fleming in
Google Scholar
PubMed
Search for other papers by Fredric Cohen in
Google Scholar
PubMed
Search for other papers by Nicola Ammer in
Google Scholar
PubMed
Search for other papers by Gilbert Mueller in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Frank Strobl in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
adult growth hormone deficiency patients: results from the ANSWER Program . Endocrine Practice 2016 22 396 – 405 . ( https://doi.org/10.4158/EP14603.OR ) 23 Biller BM Samuels MH Zagar A Cook DM Arafah BM Bonert V Stavrou S
Search for other papers by Mark R Postma in
Google Scholar
PubMed
Search for other papers by Pia Burman in
Google Scholar
PubMed
Search for other papers by André P van Beek in
Google Scholar
PubMed
areas that are affected in adults with GHD ( 24 ). The measure consists of 25 questions with ‘yes’ or ‘no’ response choices, with ‘yes’ answer indicating that the patient perceives a problem. The sum of ‘yes’ responses constitute a score, with a high